SPONSOR
Anhui Provincial Cancer Hospital
Total Trials
2
Recruiting
2
Phases
Phase 4, Phase 2
Conditions studied: Squamous Non-Small Cell Lung Cancer sqNSCLCExtensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Squamous Non-Small Cell Lung Cancer sqNSCLC, Extensive-stage Small Cell Lung Cancer (ES-SCLC).
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Anhui Provincial Cancer Hospital
How many clinical trials has Anhui Provincial Cancer Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Anhui Provincial Cancer Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Squamous Non-Small Cell Lung Cancer sqNSCLC, Extensive-stage Small Cell Lung Cancer (ES-SCLC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Anhui Provincial Cancer Hospital research focus on?
Anhui Provincial Cancer Hospital clinical trials span Squamous Non-Small Cell Lung Cancer sqNSCLC, Extensive-stage Small Cell Lung Cancer (ES-SCLC). The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Anhui Provincial Cancer Hospital clinical trial?
To participate in a Anhui Provincial Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Anhui Provincial Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Anhui Provincial Cancer Hospital
NCT07744698 Phase 4
Recruiting
Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
Squamous Non-Small Cell Lung Cancer sqNSCLC
NCT06838208 Phase 2
Recruiting
Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology